|
|
||||||||
Montreal Neurological Institute and Hospital (Drs. Hart, Andermann, and Sherwin), Montreal, Canada; the Hospital for Sick Children (Drs. Cortez and Hwang), Toronto, Canada; the National Hospital for Neurology and Neurosurgery (Dr. Fish), London, UK. Hôpital Saint Vincent de Paul (Dr. Dulac), Paris, France; the Montreal Children's Hospital (Dr. Silver), Montreal, PQ Canada; the Hospital Juan Garrahan (Drs. Fejerman and Caraballo), Buenos Aires, Argentina; and the Hospital for Sick Children (Dr. Cross), London, UK
We treated 19 patients with Rasmussen's syndrome (chronic encephalitis and epilepsy)a rare progressive disorder of unknown etiology causing focal epilepsy, hemiparesis, and intellectual deteriorationwith intravenous immunoglobulins, high-dose steroids, or both, to control seizures and improve the end point of the disease. Ten of 17 patients receiving steroids, and eight of nine patients receiving immunoglobulins, had some reduction of seizure frequency in the short term. Improvement in hemiparesis was slight. The effect of these drugs in ameliorating the end point of the disease in the long term remains unknown, and further multicenter studies with standardized protocols are warranted.
Address correspondence to Dr. F. Andermann, Montreal Neurological Institute and Hospital, 3801 University Street, Montreal, PQ, Canada H3A 2B4.
Dr. Hart is supported by a Harrison Memorial Lectureship funded by the Neurosciences Research Fund of Atkinson Morley's Hospital, London, UK.
Received August 19, 1993. Accepted for publication in final form December 13, 1993.
This article has been cited by other articles:
![]() |
C M Quesada, H Urbach, C E Elger, and C G Bien Rasmussen encephalitis with ipsilateral brain stem involvement in an adult patient J. Neurol. Neurosurg. Psychiatry, February 1, 2007; 78(2): 200 - 201. [Full Text] [PDF] |
||||
![]() |
B. Tziperman, B.-Z. Garty, N. Schoenfeld, V. Hoffer, N. Watemberg, D. Lev, Y. Ganor, M. Levite, and T. Lerman-Sagie Acute Intermittent Porphyria, Rasmussen Encephalitis, or Both? J Child Neurol, January 1, 2007; 22(1): 99 - 105. [Abstract] [PDF] |
||||
![]() |
R Gupta and R Appleton Corticosteroids in the management of the paediatric epilepsies Arch. Dis. Child., April 1, 2005; 90(4): 379 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Bien, T. Granata, C. Antozzi, J. H. Cross, O. Dulac, M. Kurthen, H. Lassmann, R. Mantegazza, J.-G. Villemure, R. Spreafico, et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: A European consensus statement Brain, March 1, 2005; 128(3): 454 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Watson, Y. Jiang, I. Bermudez, L. Houlihan, L. Clover, K. McKnight, J. H. Cross, I. K. Hart, A. Roubertie, J. Valmier, et al. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis Neurology, July 13, 2004; 63(1): 43 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Wellard, R. S. Briellmann, J. C. Wilson, R. M. Kalnins, D. P. Anderson, P. Federico, G. C. A. Fabinyi, I. E. Scheffer, A. S. Harvey, and G. D. Jackson Longitudinal study of MRS metabolites in Rasmussen encephalitis Brain, June 1, 2004; 127(6): 1302 - 1312. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Granata, L. Fusco, G. Gobbi, E. Freri, F. Ragona, G. Broggi, R. Mantegazza, L. Giordano, F. Villani, G. Capovilla, et al. Experience with immunomodulatory treatments in Rasmussen's encephalitis Neurology, December 23, 2003; 61(12): 1807 - 1810. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Bingel, J. D. Pinter, M. Sotero de Menezes, and J. M. Rho Intravenous Immunoglobulin as Adjunctive Therapy for Juvenile Spasms J Child Neurol, June 1, 2003; 18(6): 379 - 382. [Abstract] [PDF] |
||||
![]() |
A. M. Devlin, J. H. Cross, W. Harkness, W. K. Chong, B. Harding, F. Vargha-Khadem, and B. G. R. Neville Clinical outcomes of hemispherectomy for epilepsy in childhood and adolescence Brain, March 1, 2003; 126(3): 556 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Granata, G. Gobbi, R. Spreafico, F. Vigevano, G. Capovilla, F. Ragona, E. Freri, L. Chiapparini, P. Bernasconi, L. Giordano, et al. Rasmussen's encephalitis: Early characteristics allow diagnosis Neurology, February 11, 2003; 60(3): 422 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Thomas, B. Zifkin, G. Ghetau, and O. Delalande Persistence of ictal activity after functional hemispherectomy in Rasmussen syndrome Neurology, January 14, 2003; 60(1): 140 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Bien, G. Widman, H. Urbach, R. Sassen, S. Kuczaty, O. D. Wiestler, J. Schramm, and C. E. Elger The natural history of Rasmussen's encephalitis Brain, August 1, 2002; 125(8): 1751 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
C M Wiles, P Brown, H Chapel, R Guerrini, R A C Hughes, T D Martin, P McCrone, J Newsom-Davis, J Palace, J H Rees, et al. Intravenous immunoglobulin in neurological disease: a specialist review J. Neurol. Neurosurg. Psychiatry, April 1, 2002; 72(4): 440 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Bien, H. Urbach, M. Deckert, J. Schramm, O. D. Wiestler, H. Lassmann, and C. E. Elger Diagnosis and staging of Rasmussen's encephalitis by serial MRI and histopathology Neurology, January 22, 2002; 58(2): 250 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.J. Hennessy, M. Koutroumanidis, A.F. Dean, J. Jarosz, R.D.C. Elwes, C.D. Binnie, and C.E. Polkey Chronic encephalitis and temporal lobe epilepsy: A variant of Rasmussen's syndrome? Neurology, March 13, 2001; 56(5): 678 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Villani, R. Spreafico, L. Farina, A.R. Giovagnoli, P. Bernasconi, T. Granata, and G. Avanzini Positive response to immunomodulatory therapy in an adult patient with Rasmussen's encephalitis Neurology, January 23, 2001; 56(2): 248 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
J PALACE and B LANG Epilepsy: an autoimmune disease? J. Neurol. Neurosurg. Psychiatry, December 1, 2000; 69(6): 711 - 714. [Full Text] [PDF] |
||||
![]() |
S. Vinjamuri, J P Leach, and I K Hart Serial perfusion brain tomographic scans detect reversible focal ischaemia in Rasmussen's encephalitis Postgrad. Med. J., January 1, 2000; 76(891): 33 - 35. [Abstract] [Full Text] |
||||
![]() |
J. P. Leach, D. W. Chadwick, J. B. Miles, and I. K. Hart Improvement in adult-onset Rasmussen's encephalitis with long-term immunomodulatory therapy Neurology, March 1, 1999; 52(4): 738 - 738. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.O. McNamara, M. Patel, X.-P. He, S. Janumpalli, and K.D. Whitney Glutamate Receptor Autoimmunity in Rasmussen's Encephalitis Cold Spring Harb Symp Quant Biol, January 1, 1996; 61(0): 327 - 332. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |